High miR-122 expression promotes malignant phenotypes in ccRCC by targeting occludin

Kentaro Jingushi(Osaka University of Pharmaceutical Sciences), Kazutake Tsujikawa(Osaka Gakuin University)
International Journal of Oncology
May 22, 2017
Cited by 38


Related Papers